| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The human histone deacetylase family.
|
Exp Cell Res
|
2001
|
2.86
|
|
2
|
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
|
J Intern Med
|
2007
|
1.97
|
|
3
|
Epigenetic modulation at birth - altered DNA-methylation in white blood cells after Caesarean section.
|
Acta Paediatr
|
2009
|
1.95
|
|
4
|
IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome.
|
Nat Genet
|
1993
|
1.62
|
|
5
|
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.
|
Leukemia
|
2010
|
1.41
|
|
6
|
Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species.
|
Neuron
|
1990
|
1.30
|
|
7
|
In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation.
|
Proc Natl Acad Sci U S A
|
1998
|
1.21
|
|
8
|
Single gene encodes glycophospholipid-anchored and asymmetric acetylcholinesterase forms: alternative coding exons contain inverted repeat sequences.
|
Neuron
|
1990
|
1.16
|
|
9
|
Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression.
|
Development
|
1994
|
1.13
|
|
10
|
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
|
Cancer Res
|
1997
|
1.05
|
|
11
|
Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters.
|
J Endocrinol
|
1996
|
0.98
|
|
12
|
Altered expression of members of the IGF-axis in hepatoblastomas.
|
Br J Cancer
|
2000
|
0.98
|
|
13
|
Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
|
Oncogene
|
1995
|
0.97
|
|
14
|
Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
|
Endocr Relat Cancer
|
2008
|
0.93
|
|
15
|
The alpha-saturation and terminal events in dolichol biosynthesis.
|
J Biol Chem
|
1987
|
0.92
|
|
16
|
Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells.
|
Eur J Cancer
|
2004
|
0.92
|
|
17
|
Metabolic labeling of dolichol and dolichyl phosphate in isolate hepatocytes.
|
J Biol Chem
|
1984
|
0.89
|
|
18
|
Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.
|
Int J Dev Biol
|
1998
|
0.87
|
|
19
|
Epigenetic regulation in obesity.
|
Int J Obes (Lond)
|
2011
|
0.87
|
|
20
|
Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
|
Int J Cancer
|
1998
|
0.85
|
|
21
|
Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells.
|
Biochem Biophys Res Commun
|
1998
|
0.84
|
|
22
|
Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping.
|
Genomics
|
1998
|
0.84
|
|
23
|
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.
|
Exp Cell Res
|
1999
|
0.84
|
|
24
|
Methylation, gene expression and the chromatin connection in cancer (review)
|
Int J Mol Med
|
1999
|
0.84
|
|
25
|
Differential expression of class I HDACs: roles of cell density and cell cycle.
|
Int J Oncol
|
2001
|
0.84
|
|
26
|
Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
|
Exp Cell Res
|
2001
|
0.84
|
|
27
|
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
|
J Clin Endocrinol Metab
|
1999
|
0.84
|
|
28
|
Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells.
|
Int J Oncol
|
2004
|
0.83
|
|
29
|
Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis.
|
Virchows Arch
|
2001
|
0.80
|
|
30
|
GH is a regulator of IGF2 promoter-specific transcription in human liver.
|
J Endocrinol
|
2002
|
0.80
|
|
31
|
IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a.
|
Cytokine
|
2000
|
0.78
|
|
32
|
Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas.
|
J Exp Pathol (Oxford)
|
1990
|
0.78
|
|
33
|
Heparin binding growth factors and the control of teratoma cell proliferation.
|
Eur Urol
|
1993
|
0.77
|
|
34
|
Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas.
|
Cancer Lett
|
2001
|
0.76
|
|
35
|
Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas.
|
Br J Cancer
|
2000
|
0.75
|
|
36
|
Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas.
|
Biochem Biophys Res Commun
|
1997
|
0.75
|
|
37
|
Isolation of an insulin-like growth factor II cDNA from guinea pig liver: expression and developmental regulation.
|
Mol Cell Endocrinol
|
1992
|
0.75
|
|
38
|
Differentiation associated modulation of K-FGF expression in a human teratocarcinoma cell line and in primary germ cell tumours.
|
FEBS Lett
|
1991
|
0.75
|